USA Financial Formulas Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$3.77M |
| 2 |
Xcel Energy
XEL
|
+$3.3M |
| 3 |
AstraZeneca
AZN
|
+$2.78M |
| 4 |
Invesco International Dividend Achievers ETF
PID
|
+$1.37M |
| 5 |
Invesco High Yield Equity Dividend Achievers ETF
PEY
|
+$1.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$3.67M |
| 2 |
Broadcom
AVGO
|
+$3.4M |
| 3 |
Cognizant
CTSH
|
+$3.38M |
| 4 |
PepsiCo
PEP
|
+$2.82M |
| 5 |
Mondelez International
MDLZ
|
+$2.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 19.89% |
| 2 | Utilities | 18.65% |
| 3 | Healthcare | 14.58% |
| 4 | Consumer Staples | 10.61% |
| 5 | Industrials | 6.05% |
Similar funds
USA Financial Formulas's Q2 2022 Portfolio in Review
As of Q2 2022, USA Financial Formulas held 476 positions worth $80M, down 14% from $93.5M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
USA Financial Formulas withdrew a net $5.29M in Q2 2022, closing 81 positions and reducing 86 holdings. Its most notable exit was Invesco Large Cap Value ETF, an estimated $1.44M position sold in full.
By sector, the portfolio is most concentrated in Energy at 20% of assets, up from 17% a quarter earlier, followed by Utilities and Healthcare.
Against the trend, USA Financial Formulas opened a new position in Vertex Pharmaceuticals worth $3.97M.
- USA Financial Formulas's largest Q2 2022 buy was Vertex Pharmaceuticals: 14,087 shares worth $3.97M.
- USA Financial Formulas added most to Xcel Energy in Q2 2022, an estimated $3.3M increase.
- USA Financial Formulas's biggest Q2 2022 reduction was Costco, cutting an estimated $3.67M.
- USA Financial Formulas fully exited Invesco Large Cap Value ETF in Q2 2022, selling an estimated $1.44M.
- USA Financial Formulas's ten largest holdings make up 35% of its $80M portfolio in Q2 2022.
- USA Financial Formulas opened 79 new positions and closed 81 in Q2 2022.
- USA Financial Formulas's portfolio value fell 14% quarter-over-quarter to $80M.
Based on USA Financial Formulas's 13F filing for Q2 2022, filed 15 Aug 2022.